0001209191-15-073541.txt : 20151002
0001209191-15-073541.hdr.sgml : 20151002
20151002193445
ACCESSION NUMBER: 0001209191-15-073541
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151002
FILED AS OF DATE: 20151002
DATE AS OF CHANGE: 20151002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383826477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1901 OLATHE BOULEVARD
CITY: KANSAS CITY
STATE: KS
ZIP: 66103
BUSINESS PHONE: 913.951.2130
MAIL ADDRESS:
STREET 1: 1901 OLATHE BOULEVARD
CITY: KANSAS CITY
STATE: KS
ZIP: 66103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOOMAN CRAIG A
CENTRAL INDEX KEY: 0001201050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 151141835
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-02
0
0001509190
ARATANA THERAPEUTICS, INC.
PETX
0001201050
TOOMAN CRAIG A
C/O ARATANA THERAPEUTICS, INC.
1901 OLATHE BOULEVARD
KANSAS CITY
KS
66103
0
1
0
0
CHIEF FINANCIAL OFFICER
COMMON STOCK
2015-10-02
4
S
0
3250
8.058
D
73600
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015, and represents shares sold to cover tax liability incident to the vesting of shares of restricted stock.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ John C. Ayres as Attorney-in-Fact for Craig Tooman
2015-10-02